David B. Seifer

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

David B. Seifer, David T. MacLaughlin, Benjamin P. Christian et al. · Fertility and Sterility · 2002 · 495 citations

Medicine, Gynecology, Obstetrics +14

Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome

David B. Seifer, Geralyn Lambert‐Messerlian, Joseph W. Hogan et al. · Fertility and Sterility · 1997 · 327 citations

Medicine, Gynecology, Obstetrics +16

Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol

A. Hazout, Philippe Bouchard, David B. Seifer et al. · Fertility and Sterility · 2004 · 318 citations

Medicine, Gynecology, Obstetrics +15

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States

David B. Seifer, Valerie L. Baker, Benjamin Leader · Fertility and Sterility · 2010 · 299 citations · Full text

Medicine, Gynecology, Obstetrics +13

Laparoscopy in 100 women with chronic pelvic pain.

Arnold J. Kresch, David B. Seifer, Lewis B. Sachs et al. · PubMed · 1984 · 232 citations

Medicine, Gynecology, Surgery +13